VEEV Stock Recent News

Veeva Systems Inc. (NYSE:VEEV ) Q2 2025 Earnings Conference Call August 28, 2024 5:00 PM ET Company Participants Gunnar Hansen - Senior Director, Investor Relations Peter Gassner - Founder and Chief Executive Officer Tim Cabral - Interim Chief Financial Officer Paul Shawah - Executive Vice President, Commercial Strategy Conference Call Participants Joe Vruwink - Baird Saket Kalia - Barclays Ken Wong - Oppenheimer & Company Brian Peterson - Raymond James Rishi Jaluria - RBC Capital Markets Tyler Radke - Citigroup Stan Berenshteyn - Wells Fargo Securities Brent Bracelin - Piper Sandler Dylan Becker - William Blair Jack Wallace - Guggenheim Securities Carolyn Valenti - Goldman Sachs Craig Hettenbach - Morgan Stanley Ryan MacDonald - Needham Jenny Cao - Truist Securities Charles Rhyee - TD Cowen David Larsen - BTIG Operator Ladies and gentlemen, good afternoon. My name is Krista and I will be your conference operator today.

While the top- and bottom-line numbers for Veeva (VEEV) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Total Revenues of $676.2M, up 15% Year Over Year; Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif. , Aug. 28, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2024.

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.

Life sciences organizations now manage all quality control data and processes in one solution for greater efficiency and speed PLEASANTON, Calif. , Aug. 22, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced increasing momentum for Veeva Vault LIMS, a modern cloud solution that simplifies end-to-end quality control (QC) business processes.

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock. However, data security threats and escalating costs are concerning.

AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif. , Aug. 13, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that industry leaders from AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche will keynote at the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept.

PLEASANTON, Calif. , Aug. 7, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2024, after market close on August 28, 2024.

In the latest trading session, Veeva Systems (VEEV) closed at $185.47, marking a +0.18% move from the previous day.

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.